Curcumin: Preventive and Therapeutic Properties in Laboratory Studies and Clinical Trials

By A. Strimpakos, Ricky A. Sharma. Antioxidants and Redox Signaling, 2008

636 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Curcumin: Biological, Pharmaceutical, Nutraceutical, and Analytical Aspects (2019, background): “Chemical composition of turmeric consists of approximately 70% carbohydrates, 13% moisture, 6% protein, 6% essential oils (phellandrene, sabinene, cineol, borneol, zingiberene and sesquiterpenes), 5% fat, 3% mineral (potassium, calcium, phosphorus, iron, and sodium), 3–5% curcuminoids, and trace amo”
Curcumin: A Review of Its’ Effects on Human Health (2017, background): “Making cross-comparisons between the few studies that have been done can be difficult because studies have used varying doses, often as high as 1 g [57,58].”
Targets of curcumin (2011, background): “Curcumin may directly inhibit angiogenesis and also downregulate expression of various pro-angiogenic growth factors like vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), and EGF [79].”